Early and marked up-regulation of TNF-α in acute respiratory distress syndrome after cardiopulmonary bypass

Tao Li , Nanfu Luo , Lei Du , Jin Liu , Lina Gong , Jing Zhou

Front. Med. ›› 2012, Vol. 6 ›› Issue (3) : 296 -301.

PDF (180KB)
Front. Med. ›› 2012, Vol. 6 ›› Issue (3) : 296 -301. DOI: 10.1007/s11684-012-0219-1
RESEARCH ARTICLE
RESEARCH ARTICLE

Early and marked up-regulation of TNF-α in acute respiratory distress syndrome after cardiopulmonary bypass

Author information +
History +
PDF (180KB)

Abstract

Despite the technique of cardiopulmonary bypass (CPB) improved the development of modern cardiac surgery, many factors during CPB have been reported to induce acute respiratory distress syndrome (ARDS). The present study was to investigate which pro-inflammatory factors involved in the early phase of ARDS. Ten patients underwent valve replacement surgery with or without ARDS were enrolled for analysis of pulmonary function and inflammatory factors release including white blood cell (WBC), neutrophils, CD11b, CD18, interleukin (IL)-8 and tumor necrosis factor-α (TNF-α). The results demonstrated that the ratio of arterial oxygen tension/fraction of inspire oxygen (PaO2/FiO2) was greatly reduced in ARDS patients, but only the release of TNF-α was significantly increased, which was reversely correlated to the values of PaO2/FiO2. Also, the count of neutrophils adhesive to pulmonary endothelial cells was significantly increased in ARDS patients. Therefore, we concluded that TNF-α was quickly up-regulated and involved in the pathogenesis of CPB-induced ARDS via guiding primed neutrophils to pulmonary interstitium.

Keywords

tumor necrosis factor-α / cardiopulmonary bypass / inflammation / acute respiratory distress syndrome

Cite this article

Download citation ▾
Tao Li, Nanfu Luo, Lei Du, Jin Liu, Lina Gong, Jing Zhou. Early and marked up-regulation of TNF-α in acute respiratory distress syndrome after cardiopulmonary bypass. Front. Med., 2012, 6(3): 296-301 DOI:10.1007/s11684-012-0219-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest1997; 112(3): 676-692

[2]

Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med2003; 167(7): 1027-1035

[3]

Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, Randolph AG, Rubenfeld GD, Schoenfeld D, Thompson BT, Ware LB, Young D, Harabin AL. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med2010; 181(10): 1121-1127

[4]

Lin S, Walker J, Xu L, Gozal D, Yu J. Behaviours of pulmonary sensory receptors during development of acute lung injury in the rabbit. Exp Physiol2007; 92(4): 749-755

[5]

Apostolakis E, Filos KS, Koletsis E, Dougenis D. Lung dysfunction following cardiopulmonary bypass. J Card Surg2010; 25(1): 47-55

[6]

McGrath EE, Marriott HM, Lawrie A, Francis SE, Sabroe I, Renshaw SA, Dockrell DH, Whyte MKB. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol2011; 90(5): 855-865

[7]

Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury: Thomas A. Neff Lecture. Chest1999; 116(1 Suppl): 103S-110S

[8]

Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet2007; 369(9572): 1553-1564

[9]

Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol2005; 33(4): 319-327

[10]

Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol2011; 6(1): 147-163

[11]

Cross LJ, Matthay MA. Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit Care Clin2011; 27(2): 355-377

[12]

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med1994; 149(3 Pt 1): 818-824

[13]

Ottonello L, Montecucco F, Bertolotto M, Arduino N, Mancini M, Corcione A, Pistoia V, Dallegri F. CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell Signal2005; 17(3): 355-363

[14]

Zemans RL, Colgan SP, Downey GP. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol2009; 40(5): 519-535

[15]

Meyer-Hoffert U, Wiedow O. Neutrophil serine proteases: mediators of innate immune responses. Curr Opin Hematol2011; 18(1): 19-24

[16]

May AE, Neumann FJ, Schömig A, Preissner KT. VLA-4 (α(4)β(1)) engagement defines a novel activation pathway for β(2) integrin-dependent leukocyte adhesion involving the urokinase receptor. Blood2000; 96(2): 506-513

[17]

Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care2001; 7(1): 1-7

[18]

Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res2012; 110(6): 875-888

[19]

Tandon R, Sha’afi RI, Thrall RS. Neutrophil β2-integrin upregulation is blocked by a p38 MAP kinase inhibitor. Biochem Biophys Res Commun2000; 270(3): 858-862

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg

AI Summary AI Mindmap
PDF (180KB)

3050

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/